Skip to Content
Merck
  • Auxin-mediated protein depletion for metabolic engineering in terpene-producing yeast.

Auxin-mediated protein depletion for metabolic engineering in terpene-producing yeast.

Nature communications (2021-02-18)
Zeyu Lu, Bingyin Peng, Birgitta E Ebert, Geoff Dumsday, Claudia E Vickers
ABSTRACT

In metabolic engineering, loss-of-function experiments are used to understand and optimise metabolism. A conditional gene inactivation tool is required when gene deletion is lethal or detrimental to growth. Here, we exploit auxin-inducible protein degradation as a metabolic engineering approach in yeast. We demonstrate its effectiveness using terpenoid production. First, we target an essential prenyl-pyrophosphate metabolism protein, farnesyl pyrophosphate synthase (Erg20p). Degradation successfully redirects metabolic flux toward monoterpene (C10) production. Second, depleting hexokinase-2, a key protein in glucose signalling transduction, lifts glucose repression and boosts production of sesquiterpene (C15) nerolidol to 3.5 g L-1 in flask cultivation. Third, depleting acetyl-CoA carboxylase (Acc1p), another essential protein, delivers growth arrest without diminishing production capacity in nerolidol-producing yeast, providing a strategy to decouple growth and production. These studies demonstrate auxin-mediated protein degradation as an advanced tool for metabolic engineering. It also has potential for broader metabolic perturbation studies to better understand metabolism.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Geraniol, 98%
Sigma-Aldrich
(R)-(+)-Limonene, ≥93%
Sigma-Aldrich
trans,trans-Farnesol, 96%
Sigma-Aldrich
Geranylgeraniol, ≥85% (GC)